W Todd Myers Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for W Todd Myers.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of W Todd Myers. W Todd Myers is CFO in SGX PHARMACEUTICALS, INC. ($SGXP) and Chief Financial Officer in SGX PHARMACEUTICALS, INC. ($SGXP).
Latest Insider Trading Transactions of W Todd Myers
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 0.00 | 25,000 | 0 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 7.66 | 8,821 | 67,569 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 3.99 | 22,590 | 90,134 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 3.63 | 34,118 | 123,848 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 7.66 | 41,179 | 315,431 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 3.99 | 20,160 | 80,438 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | D | 3.63 | 15,882 | 57,652 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | D | 3.00 | 25,005 | 75,015 | 0 | 25 K to 0 (-100.00 %) |
| Aug 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 25,000 | |
| Aug 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 2.96 | 781 | 2,312 | 25,005 | 25.8 K to 25 K (-3.03 %) |
| Aug 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 25,786 | 24.2 K to 25.8 K (+6.45 %) |
| Jul 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 26,563 | |
| Jul 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.60 | 781 | 1,250 | 24,223 | 25 K to 24.2 K (-3.12 %) |
| Jul 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 25,004 | 23.4 K to 25 K (+6.66 %) |
| Jun 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 28,125 | |
| Jun 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.35 | 781 | 1,054 | 23,442 | 24.2 K to 23.4 K (-3.22 %) |
| Jun 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 24,223 | 22.7 K to 24.2 K (+6.90 %) |
| May 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 29,688 | |
| May 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.43 | 781 | 1,117 | 22,660 | 23.4 K to 22.7 K (-3.33 %) |
| May 06 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 23,441 | 21.9 K to 23.4 K (+7.14 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 31,250 | |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.30 | 281 | 365 | 21,879 | 22.2 K to 21.9 K (-1.27 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.34 | 200 | 268 | 22,160 | 22.4 K to 22.2 K (-0.89 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.36 | 200 | 272 | 22,360 | 22.6 K to 22.4 K (-0.89 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 1.37 | 100 | 137 | 22,560 | 22.7 K to 22.6 K (-0.44 %) |
| Apr 08 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 22,660 | 21.1 K to 22.7 K (+7.41 %) |
| Mar 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 32,813 | |
| Mar 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 4.05 | 781 | 3,163 | 21,097 | 21.9 K to 21.1 K (-3.57 %) |
| Mar 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 21,878 | 20.3 K to 21.9 K (+7.69 %) |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | A | 3.99 | 22,590 | 90,134 | 22,590 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | A | 3.99 | 20,160 | 80,438 | 20,160 | |
| Feb 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 34,375 | |
| Feb 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 4.40 | 781 | 3,436 | 20,316 | 21.1 K to 20.3 K (-3.70 %) |
| Feb 05 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 21,097 | 19.5 K to 21.1 K (+8.00 %) |
| Jan 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 35,938 | |
| Jan 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 5.15 | 781 | 4,022 | 19,534 | 20.3 K to 19.5 K (-3.84 %) |
| Jan 07 2008 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 20,315 | 18.8 K to 20.3 K (+8.33 %) |
| Dec 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 37,500 | |
| Dec 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 4.85 | 781 | 3,788 | 18,753 | 19.5 K to 18.8 K (-4.00 %) |
| Dec 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 19,534 | 18 K to 19.5 K (+8.70 %) |
| Nov 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 39,063 | |
| Nov 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 6.50 | 781 | 5,077 | 17,971 | 18.8 K to 18 K (-4.16 %) |
| Nov 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 18,752 | 17.2 K to 18.8 K (+9.09 %) |
| Oct 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 40,625 | |
| Oct 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 6.20 | 781 | 4,842 | 17,190 | 18 K to 17.2 K (-4.35 %) |
| Oct 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 17,971 | 16.4 K to 18 K (+9.53 %) |
| Sep 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 42,188 | |
| Sep 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 6.10 | 21 | 128 | 16,408 | 16.4 K to 16.4 K (-0.13 %) |
| Sep 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 6.10 | 200 | 1,220 | 16,429 | 16.6 K to 16.4 K (-1.20 %) |
| Sep 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 6.20 | 560 | 3,472 | 16,629 | 17.2 K to 16.6 K (-3.26 %) |
| Sep 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 17,189 | 15.6 K to 17.2 K (+10.00 %) |
| Aug 07 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 43,750 | |
| Aug 07 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 6.56 | 181 | 1,187 | 15,627 | 15.8 K to 15.6 K (-1.14 %) |
| Aug 07 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 6.70 | 600 | 4,020 | 15,808 | 16.4 K to 15.8 K (-3.66 %) |
| Aug 07 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 16,408 | 14.8 K to 16.4 K (+10.53 %) |
| Jul 09 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 45,313 | |
| Jul 09 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 5.33 | 781 | 4,163 | 14,845 | 15.6 K to 14.8 K (-5.00 %) |
| Jul 09 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 15,626 | 14.1 K to 15.6 K (+11.11 %) |
| Jun 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 46,875 | |
| Jun 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 5.30 | 781 | 4,139 | 14,064 | 14.8 K to 14.1 K (-5.26 %) |
| Jun 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 14,845 | 13.3 K to 14.8 K (+11.77 %) |
| May 08 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 48,438 | |
| May 08 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 5.08 | 281 | 1,427 | 13,282 | 13.6 K to 13.3 K (-2.07 %) |
| May 08 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 5.00 | 500 | 2,500 | 13,563 | 14.1 K to 13.6 K (-3.56 %) |
| May 08 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 14,063 | 12.5 K to 14.1 K (+12.50 %) |
| Apr 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 50,000 | |
| Apr 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 4.61 | 781 | 3,600 | 12,501 | 13.3 K to 12.5 K (-5.88 %) |
| Apr 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 13,282 | 11.7 K to 13.3 K (+13.34 %) |
| Mar 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,562 | 0 | 51,563 | |
| Mar 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 4.83 | 781 | 3,772 | 11,719 | 12.5 K to 11.7 K (-6.25 %) |
| Mar 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,562 | 0 | 12,500 | 10.9 K to 12.5 K (+14.28 %) |
| Feb 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | M | 0.00 | 1,563 | 0 | 53,125 | |
| Feb 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Sell | S | 3.90 | 781 | 3,046 | 10,938 | 11.7 K to 10.9 K (-6.66 %) |
| Feb 05 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Buy | M | 0.00 | 1,563 | 0 | 11,719 | 10.2 K to 11.7 K (+15.39 %) |
| Jan 29 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | A | 3.63 | 34,118 | 123,848 | 34,118 | |
| Jan 29 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | CFO | Option Exercise | A | 3.63 | 15,882 | 57,652 | 15,882 | |
| Jan 08 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,562 | 0 | 54,688 | |
| Jan 08 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | Chief Financial Off ... | Sell | S | 3.25 | 150 | 488 | 10,156 | 10.3 K to 10.2 K (-1.46 %) |
| Jan 08 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | Chief Financial Off ... | Sell | S | 3.20 | 631 | 2,019 | 10,306 | 10.9 K to 10.3 K (-5.77 %) |
| Jan 08 2007 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | Chief Financial Off ... | Buy | M | 0.00 | 1,562 | 0 | 10,937 | 9.4 K to 10.9 K (+16.66 %) |
| Mar 09 2006 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | Chief Financial Off ... | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
| Mar 09 2006 | SGXP | SGX PHARMACEUTICAL ... | Myers W Todd | Chief Financial Off ... | Option Exercise | A | 7.66 | 50,000 | 383,000 | 50,000 |
Page: 1